Calvenza Flu + Rhino (EIV/EHV) Vaccine
Equine Rhinopneumonitis + Influenza Vaccine
For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in reduction of respiratory diseases caused by equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4), and by equine influenza virus types A2 North American and A2 Eurasian.
CALVENZA family of vaccines:
- CALVENZA EHV
- CALVENZA -03 EIV
- CALVENZA -03 EIV/EHV
- Incorporates Florida sublineage Clade 1 (OH/03), Kentucky (KY/2/95), and Eurasian (NM/2/93) equine influenza strains
- Unique EHV-1 equine respiratory origin isolate
- Stimulates antibody to EHV-1 & EVH-4
- Carbimmune adjuvant
- Includes innovative pliable nasal applicator
- Flexible dose administration using intramuscular or intranasal techniques
- Minimal vaccine site reactions
This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy in normal, healthy, immunocompetent animals. This level of performance may be affected by conditions such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.
Store at a temperature between 35° – 45° F (2° – 7° C). Protect from freezing. Shake well before using. Do not vaccinate within 21 days of slaughter.
DOSAGE & ADMINISTRATION:
Using aseptic technique inoculate horses IM with a 2 mL dose. Administer a second 2 mL dose IM in 3-4 weeks using a different injection site if first time receiving vaccine. Administer a third 2 mL dose in 3-4 weeks IM or IN.
USEF Regulations: The 12 hour injection rule only applies, but the shows themselves and FEI may require a certain schedule to be followed for Flu/Rhino.
Returns: Vaccines cannot be returned.